Harrow Health, Inc.

NASDAQ:HROW

Drug Manufacturers - Specialty & Generic

Healthcare
$32.16 +0.29%

+$0.12 today

Market cap
$1.21B
Beta
0.28
P/E (TTM)
-104.7
EPS (TTM)
-$0.40
52W Low $28.54High $54.85

Volume 0.87M

Average 0.75M

HROW Total Equity

Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.

Harrow Health, Inc.NASDAQ: HROW

Total Equity · Q1 FY2026 · quarter ended Mar 2026

Total equity falls 49.5% from a year ago

Total equity stood at $28.35M at the end of Q1 FY2026, down 49.5% from a year earlier and down 45.6% from the prior quarter. Over 3 fiscal years it compounded at +24.1% a year.

Context

  • Total equity amounted to 6.8% of total assets at the end of Q1 FY2026, down 8.6 pp from a year earlier.
  • Total equity increased in 1 of the last 3 fiscal years.

What to watch

Whether total equity keeps falling in the next quarterly balance sheet after a -49.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$28.35M-45.6% QoQ
Last fiscal yearDec 2025
$52.09M-24.8% YoY
Year agoMar 2025
$56.1M-49.5% since
Total Equity past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-49.5%——
1 year-24.8%——
3-year CAGR+24.1%——
5-year CAGR——
10-year CAGR——

Total Equity history

USD · from the balance sheet

Latest · FY2025
52.09M USD
Year-over-year change
-24.8%
4-year CAGR
+47.7%

Total Equity vs competitors

How HROW compares with its peers on the latest reported figures

  • Peers report in different currencies, so total equity is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -49.5% is the 7th highest of 8, against a peer median of -1.0%.
  • Total equity amounts to 6.8% of total assets for HROW, versus a peer median of 62.9%.
HROW Competitors
Total Equity for HROW and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BLCOBausch + Lomb CorporationJun 2026$6.44B USD-1.0%-2.8%46.5%
OCULOcular Therapeutix, Inc.Mar 2026$581.57M USD+118.7%+164.5%79.4%
EYPTEyePoint Pharmaceuticals, Inc.Mar 2026$230.47M USD-22.8%+47.0%80.0%
OCSOculis Holding AGMar 2026CHF 196.06M CHF+20.6%—80.6%
TARSTarsus Pharmaceuticals, Inc.Sep 2026$104.03M USD-69.0%+21.2%20.6%
HROWHarrow Health, Inc.Mar 2026$28.35M USD-49.5%+24.1%6.8%
KODKodiak Sciences Inc.Sep 2026$12.57M USD-46.9%-28.8%6.0%
TTRXTurn Therapeutics Inc.Mar 2026$6.12M USD——32.8%
OTLKOutlook Therapeutics, Inc.Mar 2026-$28.99M USD+10.7%—132.4%
Peer median (excluding HROW) —-1.0%+21.2%62.9%

Competitors are the stored peer set for HROW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents42.17M96.27M74.09M47.25M72.93M
Short-term Investments8.5M5.59M8.68M00
Net Receivables4.52M6.39M36.49M116.6M110.9M
Inventory4.22M6.54M10.87M10.7M13.52M
Other Current Assets92K118K1.75M3.41M2.13M
Total Current Assets60.66M118.26M139.07M189.65M211.75M
Property, Plant & Equipment (Net)9.08M11M12.44M12.29M11.04M
Goodwill332K332K332K332K332K
Intangible Assets17.13M25.84M159.91M186.7M175.17M
Long-term Investments11.13M0000
Tax Assets(12.45M)0000
Other Non-current Assets12.45M1.95M001.18M
Total Non-current Assets37.67M39.12M172.68M199.32M187.73M
Total Assets98.33M157.38M311.76M388.97M399.48M
Account Payables5.17M6.44M21.42M38.76M35.36M
Short-term Debt00806K0887K
Tax Payables00000
Deferred Revenue16K113K044K788K
Other Current Liabilities1.16M021.66M059.27M
Total Current Liabilities9.72M18.63M49.34M91.34M96.3M
Long-term Debt71.65M104.17M183.17M219.54M243.18M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities002.71M00
Total Non-current Liabilities77.68M111.51M192.41M228.33M251.09M
Total Liabilities87.4M130.14M241.75M319.67M347.39M
Common Stock27K30K35K35K37K
Retained Earnings(95.41M)(109.49M)(133.9M)(151.39M)(156.52M)
Accumulated OCI00(409K)00
Other Stockholders Equity00000
Minority Interest(355K)(355K)(355K)(355K)(355K)
Total Equity10.93M27.24M70M69.3M52.09M
Total Debt77.96M112.23M190.5M228.83M251.98M
Net Debt35.79M15.96M116.42M181.58M179.05M

Harrow Health, Inc.

NASDAQ:HROW

Intrinsic Alpha fair value

Locked

Current Price

$32.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.